Phase 2 Refractory Ewing Sarcoma Clinical Trials

3 recruitingPhase 2

What is a Phase 2 trial?

Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.

Showing 1–3 of 3 trials

Recruiting

Phase 1Phase 2

Study of Onivyde With Talazoparib or Temozolomide in Children With Recurrent Solid Tumors and Ewing Sarcoma

Recurrent Malignant Solid NeoplasmRefractory Malignant Solid NeoplasmRecurrent Solid Tumor+19 more

St. Jude Children's Research Hospital90 enrolled10 locationsNCT04901702

Recruiting

Phase 1Phase 2

Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

Ovarian CarcinomaColorectal CarcinomaMelanoma+19 more

Children's Oncology Group147 enrolled21 locationsNCT04851119

Recruiting

Phase 1Phase 2

Study of Lurbinectedin Monotherapy in Pediatric and Young Adult Participants With Relapsed/Refractory Ewing Sarcoma

Ewing SarcomaRefractory Ewing SarcomaRelapsed Ewing Sarcoma

Jazz Pharmaceuticals60 enrolled15 locationsNCT05734066